
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1308397
[patent_doc_number] => 06617436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-09
[patent_title] => 'Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same'
[patent_app_type] => B2
[patent_app_number] => 09/736447
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4338
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617436.pdf
[firstpage_image] =>[orig_patent_app_number] => 09736447
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/736447 | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same | Dec 14, 2000 | Issued |
Array
(
[id] => 7367161
[patent_doc_number] => 20040006012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Pharmaceutical compositions'
[patent_app_type] => new
[patent_app_number] => 09/738104
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7603
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006012.pdf
[firstpage_image] =>[orig_patent_app_number] => 09738104
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/738104 | Pharmaceutical compositions | Dec 14, 2000 | Issued |
Array
(
[id] => 1327767
[patent_doc_number] => 06599884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-29
[patent_title] => 'Processes for preparing clarithromycin polymorphs and novel polymorph IV'
[patent_app_type] => B2
[patent_app_number] => 09/736449
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5329
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599884.pdf
[firstpage_image] =>[orig_patent_app_number] => 09736449
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/736449 | Processes for preparing clarithromycin polymorphs and novel polymorph IV | Dec 14, 2000 | Issued |
Array
(
[id] => 6476605
[patent_doc_number] => 20020022586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Method for treating a patient with neoplasia by treatment with a pyrimidine analog'
[patent_app_type] => new
[patent_app_number] => 09/734633
[patent_app_country] => US
[patent_app_date] => 2000-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9554
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022586.pdf
[firstpage_image] =>[orig_patent_app_number] => 09734633
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/734633 | Method for treating a patient with neoplasia by treatment with a pyrimidine analog | Dec 11, 2000 | Abandoned |
Array
(
[id] => 1453848
[patent_doc_number] => 06462025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-10-08
[patent_title] => 'Antibiotic/benzoyl peroxide dispenser'
[patent_app_type] => B2
[patent_app_number] => 09/734748
[patent_app_country] => US
[patent_app_date] => 2000-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3528
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/462/06462025.pdf
[firstpage_image] =>[orig_patent_app_number] => 09734748
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/734748 | Antibiotic/benzoyl peroxide dispenser | Dec 11, 2000 | Issued |
Array
(
[id] => 1470892
[patent_doc_number] => 06407257
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Derivatives of erythromycin, their preparation process and their use as medicaments'
[patent_app_type] => B1
[patent_app_number] => 09/734162
[patent_app_country] => US
[patent_app_date] => 2000-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2627
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407257.pdf
[firstpage_image] =>[orig_patent_app_number] => 09734162
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/734162 | Derivatives of erythromycin, their preparation process and their use as medicaments | Dec 10, 2000 | Issued |
Array
(
[id] => 1034545
[patent_doc_number] => 06875755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-05
[patent_title] => 'Antithrombotic compound'
[patent_app_type] => utility
[patent_app_number] => 10/148868
[patent_app_country] => US
[patent_app_date] => 2000-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6610
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875755.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148868 | Antithrombotic compound | Nov 30, 2000 | Issued |
Array
(
[id] => 1420321
[patent_doc_number] => 06506742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-14
[patent_title] => 'Soluble contraceptive liquid formulation'
[patent_app_type] => B2
[patent_app_number] => 09/727871
[patent_app_country] => US
[patent_app_date] => 2000-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2855
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/506/06506742.pdf
[firstpage_image] =>[orig_patent_app_number] => 09727871
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/727871 | Soluble contraceptive liquid formulation | Nov 30, 2000 | Issued |
Array
(
[id] => 1131178
[patent_doc_number] => 06787568
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'Antibiotic/analgesic formulation and a method of making this formulation'
[patent_app_type] => B1
[patent_app_number] => 09/723064
[patent_app_country] => US
[patent_app_date] => 2000-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2918
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787568.pdf
[firstpage_image] =>[orig_patent_app_number] => 09723064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/723064 | Antibiotic/analgesic formulation and a method of making this formulation | Nov 26, 2000 | Issued |
Array
(
[id] => 1479521
[patent_doc_number] => 06451990
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Azithromycin preparation in its noncryst alline and crystalline dihydrate forms'
[patent_app_type] => B1
[patent_app_number] => 09/718833
[patent_app_country] => US
[patent_app_date] => 2000-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2829
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451990.pdf
[firstpage_image] =>[orig_patent_app_number] => 09718833
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/718833 | Azithromycin preparation in its noncryst alline and crystalline dihydrate forms | Nov 21, 2000 | Issued |
Array
(
[id] => 1417510
[patent_doc_number] => 06518251
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-11
[patent_title] => 'Macrolides'
[patent_app_type] => B1
[patent_app_number] => 09/715394
[patent_app_country] => US
[patent_app_date] => 2000-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10847
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1499
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/518/06518251.pdf
[firstpage_image] =>[orig_patent_app_number] => 09715394
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/715394 | Macrolides | Nov 16, 2000 | Issued |
Array
(
[id] => 1515463
[patent_doc_number] => 06420537
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Macrolide production'
[patent_app_type] => B1
[patent_app_number] => 09/707566
[patent_app_country] => US
[patent_app_date] => 2000-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4617
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420537.pdf
[firstpage_image] =>[orig_patent_app_number] => 09707566
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/707566 | Macrolide production | Nov 6, 2000 | Issued |
Array
(
[id] => 1596113
[patent_doc_number] => 06492342
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Hygromycin A prodrugs'
[patent_app_type] => B1
[patent_app_number] => 09/698399
[patent_app_country] => US
[patent_app_date] => 2000-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7291
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 399
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492342.pdf
[firstpage_image] =>[orig_patent_app_number] => 09698399
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/698399 | Hygromycin A prodrugs | Oct 26, 2000 | Issued |
Array
(
[id] => 1470158
[patent_doc_number] => 06407071
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Method and composition for treating malignant cells'
[patent_app_type] => B1
[patent_app_number] => 09/694679
[patent_app_country] => US
[patent_app_date] => 2000-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11477
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407071.pdf
[firstpage_image] =>[orig_patent_app_number] => 09694679
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/694679 | Method and composition for treating malignant cells | Oct 23, 2000 | Issued |
Array
(
[id] => 1546418
[patent_doc_number] => 06444796
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Method of preparing form II crystals of clarithromycin'
[patent_app_type] => B1
[patent_app_number] => 09/693795
[patent_app_country] => US
[patent_app_date] => 2000-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 3205
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444796.pdf
[firstpage_image] =>[orig_patent_app_number] => 09693795
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/693795 | Method of preparing form II crystals of clarithromycin | Oct 19, 2000 | Issued |
Array
(
[id] => 1373200
[patent_doc_number] => 06562792
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Hygromycin derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/693118
[patent_app_country] => US
[patent_app_date] => 2000-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50045
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2004
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562792.pdf
[firstpage_image] =>[orig_patent_app_number] => 09693118
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/693118 | Hygromycin derivatives | Oct 19, 2000 | Issued |
Array
(
[id] => 1342315
[patent_doc_number] => 06590083
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-08
[patent_title] => 'Ketolide antibacterials'
[patent_app_type] => B1
[patent_app_number] => 09/691540
[patent_app_country] => US
[patent_app_date] => 2000-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32247
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/590/06590083.pdf
[firstpage_image] =>[orig_patent_app_number] => 09691540
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/691540 | Ketolide antibacterials | Oct 17, 2000 | Issued |
Array
(
[id] => 1570460
[patent_doc_number] => 06498146
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Erythromycin derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/688679
[patent_app_country] => US
[patent_app_date] => 2000-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11413
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 639
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498146.pdf
[firstpage_image] =>[orig_patent_app_number] => 09688679
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/688679 | Erythromycin derivatives | Oct 15, 2000 | Issued |
Array
(
[id] => 1417527
[patent_doc_number] => 06509319
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-21
[patent_title] => 'EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections'
[patent_app_type] => B1
[patent_app_number] => 09/680061
[patent_app_country] => US
[patent_app_date] => 2000-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12924
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/509/06509319.pdf
[firstpage_image] =>[orig_patent_app_number] => 09680061
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/680061 | EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections | Oct 3, 2000 | Issued |
Array
(
[id] => 1446816
[patent_doc_number] => 06369037
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Controlled release of doxorubicin'
[patent_app_type] => B1
[patent_app_number] => 09/677859
[patent_app_country] => US
[patent_app_date] => 2000-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3786
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369037.pdf
[firstpage_image] =>[orig_patent_app_number] => 09677859
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/677859 | Controlled release of doxorubicin | Oct 2, 2000 | Issued |